IHF — iShares U.S. Healthcare Providers ETF
Healthcare Ranked #293 of 458 tracked ETFs · Issued by iShares
IHF Price Performance — Growth of $10,000
Value of a $10,000 investment in IHF over time, compared with SPY. Both lines are rebased to $10,000 on the first shared date. Based on total returns — prices are adjusted for dividends and splits, so this assumes distributions were reinvested. Hover or tap the chart for exact values.
IHF Drawdown
The "underwater" chart: IHF's decline from its highest prior value at each point in time. It shows how deep past losses ran and how long the fund took to recover to break-even.
What If You'd Invested in IHF?
See what a lump sum in IHF would have grown to, with the option to add a regular monthly contribution on top. Figures use total returns — dividends are assumed reinvested.
Past performance doesn't predict future results. Assumes contributions on the first trading day of each month, no trading costs or taxes, and reinvested distributions. History is limited to the range published in the site's daily return data.
Overview
The iShares U.S. Healthcare Providers ETF (IHF) operates within the Healthcare category, which ETFValuer currently tracks with 11 funds. Issued by iShares, this fund holds an asset base of $1.18 billion and trades at a price of $56.49 per share. It carries an overall rank of #293 out of 458 tracked ETFs across all categories and has received an ETFValuer grade of C with a score of 57.3 out of 100. The fund charges an expense ratio of 0.38% while offering a dividend yield of 0.94%. The combination of a mid-tier rank and a moderate asset size suggests a specific level of investor adoption relative to the broader universe of tracked funds. These metrics collectively define the fund's current standing and cost structure for potential investors.
Recent performance data shows a daily return of +0.68% followed by a weekly decline of -0.26%, indicating short-term volatility. Over the past month, the fund gained +5.59%, which accelerated into a +20.64% return over the three-month period. Year-to-date returns stand at +17.24%, while the one-year return reached +30.54%. Longer-term data shows a three-year annualized return of +10.99%, suggesting a sustained upward trend over the multi-year horizon. The progression from a modest one-month gain to a significant one-year return highlights a pattern of acceleration in performance over the last twelve months.
IHF is assigned a Moderate volatility label and exhibits a beta of 0.85, indicating that the fund has historically moved less than the broader market. A Sharpe ratio of 1.22 suggests the fund has generated a favorable risk-adjusted return relative to its volatility. However, the fund experienced a maximum drawdown of -29.85%, reflecting the severity of its largest peak-to-trough decline. This combination of a beta below 1.0 and a high Sharpe ratio implies the fund has offered efficient returns during its up periods despite the significant drawdown. The moderate volatility classification aligns with the beta figure, while the max drawdown figure provides context for the potential downside risk investors have faced.
AI-generated summary based on the data on this page.
IHF Top Holdings
| # | Holding | % of Net Assets | Value |
|---|---|---|---|
| 1 | UNITEDHEALTH GROUP INCORPORATED | 22.48% | $146M |
| 2 | CVS HEALTH CORPORATION | 12.81% | $83M |
| 3 | HCA HEALTHCARE, INC. | 8.98% | $58M |
| 4 | THE CIGNA GROUP | 4.85% | $31M |
| 5 | ELEVANCE HEALTH, INC. | 4.79% | $31M |
| 6 | VEEVA SYSTEMS INC. | 4.45% | $29M |
| 7 | LABCORP HOLDINGS INC. | 4.01% | $26M |
| 8 | QUEST DIAGNOSTICS INCORPORATED | 3.91% | $25M |
| 9 | HUMANA INC. | 3.79% | $25M |
| 10 | TENET HEALTHCARE CORPORATION | 3.01% | $19M |
Holdings as of 2026-03-31 per the fund's most recent SEC N-PORT-P filing. Top 10 holdings make up 73.1% of net assets — a rough gauge of concentration risk (the higher this figure, the more the fund's return depends on a handful of names). To see how IHF's holdings overlap with other ETFs you own or are considering, check the Stock Overlap tool.
Which Funds Overlap With IHF
Holding two funds that own the same companies adds cost and complexity without adding much diversification. These tracked ETFs share the most names with IHF's top 10 — VFVA overlaps most, holding 2 of the same companies as IHF's top 10 (17.7% of IHF's assets).
| ETF | Name | Shared Companies | IHF Weight | Examples |
|---|---|---|---|---|
| VFVA | Vanguard U.S. Value Factor ETF Shares | 2 | 17.7% | CVS HEALTH CORPORATION, THE CIGNA GROUP |
| SCHD | Schwab U.S. Dividend Equity ETF | 1 | 22.5% | UNITEDHEALTH GROUP INCORPORATED |
| DGRO | iShares Core Dividend Growth ETF | 1 | 22.5% | UNITEDHEALTH GROUP INCORPORATED |
| VHT | Vanguard Health Care Index Fund ETF Shares | 1 | 22.5% | UNITEDHEALTH GROUP INCORPORATED |
| XLV | State Street Health Care Select Sector SPDR ETF | 1 | 22.5% | UNITEDHEALTH GROUP INCORPORATED |
Compares the top 10 reported holdings of each fund, so it's a floor on true overlap — two S&P 500 trackers overlap ~100% even when only 10 names are listed. Use the Stock Overlap tool to search by individual company.
Market Backdrop
10-Year Treasury Yield: 4.71% (as of 2026-07-23) — The yield on 10-year US Treasury bonds — the standard "risk-free rate" benchmark used to contextualize this fund’s Sharpe ratio and returns.
CBOE Volatility Index (VIX): 18.70 (as of 2026-07-23) — A real-time gauge of expected S&P 500 volatility over the next 30 days — useful context for this fund’s own volatility label.
Federal Funds Rate: 3.63% (as of 2026-06-01) — The Federal Reserve’s target policy rate, which anchors short-term borrowing costs across the economy.
What IHF's Fees Cost You
IHF charges an expense ratio of 0.38% a year, deducted automatically from the fund's value. Small percentages compound into real money — adjust the figures below to see the impact on your own numbers.
Assumes a constant gross return and no additional contributions — a simplification, but it isolates exactly what the expense ratio costs. Try the full fee calculator to model contributions and compare any two funds.
IHF Dividend Income Estimator
IHF currently yields 0.94%. Enter an amount to see the income that implies, or set a monthly income target to see the investment it would take.
Based on the fund's current trailing yield, which varies with price and distributions — treat it as an estimate, not a guarantee. Yields are not adjusted for tax.
IHF Liquidity, Domicile & Tax Treatment
Liquidity: Quoted bid/ask spread is 1.32% and average daily volume is 500K/day. Tighter spreads and higher volume mean lower round-trip trading costs; this is a live-market snapshot and can widen during volatile sessions. AUM of $1.18B provides ample scale, supporting tight spreads and issuer commitment to keep the fund open.
Domicile & tax treatment: IHF is a US-domiciled, SEC-registered ('40 Act) exchange-traded fund. Dividends and capital gains distributions are reported to US investors on Form 1099-DIV, and the fund is not subject to the PFIC reporting or UCITS-specific rules that apply to Irish- or Luxembourg-domiciled funds. Non-US investors should note that US-domiciled ETFs are generally subject to 30% US withholding tax on dividends (unless reduced by treaty) and to US estate tax exposure on the position — Irish-domiciled UCITS ETFs tracking the same index often avoid both, which is why non-US residents frequently prefer the UCITS equivalent where one exists. This is general information, not tax advice — consult a tax professional for your situation.
IHF Performance History
| Period | Return |
|---|---|
| 1-Day | +0.68% |
| 1-Week | -0.26% |
| 1-Month | +5.59% |
| 3-Month | +20.64% |
| 6-Month | +13.33% |
| YTD | +17.24% |
| 1-Year | +30.54% |
| 3-Year | +10.99% |
How IHF Compares to Other Healthcare ETFs
| Rank | Grade | Ticker | Name | 1-Year | Exp. Ratio | AUM |
|---|---|---|---|---|---|---|
| #66 | B |
XBI | State Street SPDR S&P Biotech ETF | +71.35% | 0.35% | $10.7B |
| #69 | B |
VHT | Vanguard Health Care Index Fund ETF Shares | +23.45% | 0.09% | $20.4B |
| #92 | B |
XLV | State Street Health Care Select Sector SPDR ETF | +21.38% | 0.08% | $40.6B |
| #110 | B |
FHLC | Fidelity MSCI Health Care Index ETF | +23.55% | 0.084% | $3.22B |
| #122 | B |
XPH | State Street SPDR S&P Pharmaceuticals ETF | +57.67% | 0.35% | $428M |
| #125 | B |
IBB | iShares Biotechnology ETF | +39.29% | 0.44% | $9.09B |
| #172 | B |
PPH | VanEck Pharmaceutical ETF | +26.45% | 0.36% | $879M |
| #198 | C |
IYH | iShares U.S. Healthcare ETF | +21.01% | 0.38% | $3.16B |
| #293 | C |
IHF | iShares U.S. Healthcare Providers ETF | +30.54% | 0.38% | $1.18B |
| #389 | D |
ARKG | ARK Genomic Revolution ETF | +42.41% | 0.75% | $1.73B |
| #443 | F |
IHI | iShares U.S. Medical Devices ETF | -17.48% | 0.38% | $3.02B |